Blog Posts in December, 2004

  • Where is the FDA?

    We have been bombarded this holiday season with bad news. Drugs distributed on a mass scale have the ability to actually kill its users. Vioxx, Celebrex, and Bextra, all members of a class of drugs called Cox-2 inhibitors, are the problem. The first to fall is Vioxx. Merck Pharmaceuticals withdrew Vioxx from the market after a study indicated a two fold risk of heart attack with people who use the ...
    Continue Reading
  • FDA Statement on the Halting of a Clinical Trial of the Cox-2 Inhibitor Celebrex

    FDA Statement on the Halting of a Clinical Trial of the Cox-2 Inhibitor Celebrex FOR IMMEDIATE RELEASE: Statement - Dec. 17, 2004 The FDA today released the following statement on the halting of a clinical trial of the Cox-2 inhibitor Celebrex (celecoxib): The Food and Drug Administration (FDA) learned last night from the National Cancer Institute (NCI) and Pfizer, Inc., that NCI has stopped drug ...
    Continue Reading
Page 1 of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.